BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 9524835)

  • 1. Varying titers of neutralizing antibodies to streptococcal superantigens in different preparations of normal polyspecific immunoglobulin G: implications for therapeutic efficacy.
    Norrby-Teglund A; Basma H; Andersson J; McGeer A; Low DE; Kotb M
    Clin Infect Dis; 1998 Mar; 26(3):631-8. PubMed ID: 9524835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in potency of intravenous polyspecific immunoglobulin G against streptococcal and staphylococcal superantigens: implications for therapy of toxic shock syndrome.
    Darenberg J; Söderquist B; Normark BH; Norrby-Teglund A
    Clin Infect Dis; 2004 Mar; 38(6):836-42. PubMed ID: 14999628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for the presence of streptococcal-superantigen-neutralizing antibodies in normal polyspecific immunoglobulin G.
    Norrby-Teglund A; Kaul R; Low DE; McGeer A; Andersson J; Andersson U; Kotb M
    Infect Immun; 1996 Dec; 64(12):5395-8. PubMed ID: 8945593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative neutralizing activity in polyspecific IgM, IgA, and IgG preparations against group A streptococcal superantigens.
    Norrby-Teglund A; Ihendyane N; Kansal R; Basma H; Kotb M; Andersson J; Hammarström L
    Clin Infect Dis; 2000 Nov; 31(5):1175-82. PubMed ID: 11073749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma from patients with severe invasive group A streptococcal infections treated with normal polyspecific IgG inhibits streptococcal superantigen-induced T cell proliferation and cytokine production.
    Norrby-Teglund A; Kaul R; Low DE; McGeer A; Newton DW; Andersson J; Andersson U; Kotb M
    J Immunol; 1996 Apr; 156(8):3057-64. PubMed ID: 8609429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Streptococcal superantigen-induced expansion of human tonsil T cells leads to altered T follicular helper cell phenotype, B cell death and reduced immunoglobulin release.
    Davies FJ; Olme C; Lynskey NN; Turner CE; Sriskandan S
    Clin Exp Immunol; 2019 Jul; 197(1):83-94. PubMed ID: 30815853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opsonic antibodies to the surface M protein of group A streptococci in pooled normal immunoglobulins (IVIG): potential impact on the clinical efficacy of IVIG therapy for severe invasive group A streptococcal infections.
    Basma H; Norrby-Teglund A; McGeer A; Low DE; El-Ahmedy O; Dale JB; Schwartz B; Kotb M
    Infect Immun; 1998 May; 66(5):2279-83. PubMed ID: 9573118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different preparations of intravenous immunoglobulin vary in their efficacy to neutralize streptococcal superantigens: implications for treatment of streptococcal toxic shock syndrome.
    Schrage B; Duan G; Yang LP; Fraser JD; Proft T
    Clin Infect Dis; 2006 Sep; 43(6):743-6. PubMed ID: 16912949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superantigenic activity produced by group A streptococcal isolates is neutralized by plasma from IVIG-treated streptococcal toxic shock syndrome patients.
    Norrby-Teglund A; Low DE; McGeer A; Kotb M
    Adv Exp Med Biol; 1997; 418():563-6. PubMed ID: 9331714
    [No Abstract]   [Full Text] [Related]  

  • 10. Serologic evidence that streptococcal superantigens are not involved in the pathogenesis of Kawasaki disease.
    Morita A; Imada Y; Igarashi H; Yutsudo T
    Microbiol Immunol; 1997; 41(11):895-900. PubMed ID: 9444333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of serum IgM antibodies against superantigens of Staphylococcus aureus and Streptococcus pyogenes in Kawasaki disease.
    Matsubara K; Fukaya T; Miwa K; Shibayama N; Nigami H; Harigaya H; Nozaki H; Hirata T; Baba K; Suzuki T; Ishiguro A
    Clin Exp Immunol; 2006 Mar; 143(3):427-34. PubMed ID: 16487241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative avidities of human immunoglobulin G antibodies for streptococcal pyrogenic exotoxins A and B.
    Mascini EM; Jansze M; Verhoef J; van Dijk H
    Clin Diagn Lab Immunol; 1999 Nov; 6(6):977-80. PubMed ID: 10548596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basic streptococcal superantigens (SPEX/SMEZ or SPEC) are responsible for the mitogenic activity of the so-called mitogenic factor (MF).
    Gerlach D; Schmidt KH; Fleischer B
    FEMS Immunol Med Microbiol; 2001 Apr; 30(3):209-16. PubMed ID: 11335140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential presentation of group A streptococcal superantigens by HLA class II DQ and DR alleles.
    Norrby-Teglund A; Nepom GT; Kotb M
    Eur J Immunol; 2002 Sep; 32(9):2570-7. PubMed ID: 12207341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutralization of staphylococcal exotoxins in vitro by human-origin intravenous immunoglobulin.
    Yanagisawa C; Hanaki H; Natae T; Sunakawa K
    J Infect Chemother; 2007 Dec; 13(6):368-72. PubMed ID: 18095084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors in the pathogenesis of invasive group A streptococcal infections: role of protective humoral immunity.
    Basma H; Norrby-Teglund A; Guedez Y; McGeer A; Low DE; El-Ahmedy O; Schwartz B; Kotb M
    Infect Immun; 1999 Apr; 67(4):1871-7. PubMed ID: 10085030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyrogenicity and cytokine-inducing properties of Streptococcus pyogenes superantigens: comparative study of streptococcal mitogenic exotoxin Z and pyrogenic exotoxin A.
    Müller-Alouf H; Proft T; Zollner TM; Gerlach D; Champagne E; Desreumaux P; Fitting C; Geoffroy-Fauvet C; Alouf JE; Cavaillon JM
    Infect Immun; 2001 Jun; 69(6):4141-5. PubMed ID: 11349089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Superantigens and streptococcal toxic shock syndrome.
    Proft T; Sriskandan S; Yang L; Fraser JD
    Emerg Infect Dis; 2003 Oct; 9(10):1211-8. PubMed ID: 14609454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphokine production induced by streptococcal pyrogenic exotoxin-A is selectively down-regulated by pooled human IgG.
    Skansén-Saphir U; Andersson J; Björk L; Andersson U
    Eur J Immunol; 1994 Apr; 24(4):916-22. PubMed ID: 8149962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the interaction between the bacterial superantigen streptococcal pyrogenic exotoxin A (SpeA) and the human T-cell receptor.
    Kline JB; Collins CM
    Mol Microbiol; 1997 Apr; 24(1):191-202. PubMed ID: 9140976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.